CD14分子(CD14)多克隆抗體
Polyclonal Antibody to Cluster Of Differentiation 14 (CD14)
Monocyte differentiation antigen CD14; Myeloid cell-specific leucine-rich glycoprotein
- 編號PAA685Hu02
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 免疫原 RPA685Hu02-CD14分子(CD14)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性狀液體
- 濃度500μg/mL
- 且適物種-
- 應(yīng)用WB; IHC; ICC; IP.
如果抗體需用于流式細胞術(shù)，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 589 ¥ 1373 ¥ 1962 ¥ 4905 ¥ 19620
- 欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
DAB staining on IHC-P; Sample: Human Spleen Tissue; Primary Ab: 20μg/ml Rabbit Anti-Human CD14 Antibody Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody (Catalog: SAA544Rb19)
-
Western Blot; Sample: Lane1: Human Milk; Lane2: Human Urine Primary Ab: 0.2μg/ml Rabbit Anti-Human CD14 Antibody Second Ab: 0.2μg/mL HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody (Catalog: SAA544Rb19)
-
通過ISO 9001、ISO 13485質(zhì)量體系認證
特異性
該抗體是針對CD14的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實驗中能識別CD14。
用法
Western blotting: 0.5-2μg/mL
Immunohistochemistry: 5-20μg/mL
Immunocytochemistry: 5-20μg/mL
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| EPA685Hu62 | CD14分子(CD14)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APA685Hu62 | CD14分子(CD14)活性蛋白 | Cell?culture;?Activity?Assays. |
| APA685Hu01 | CD14分子(CD14)活性蛋白 | Cell?culture;?Activity?Assays. |
| RPA685Hu02 | CD14分子(CD14)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA685Hu01 | CD14分子(CD14)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APA685Hu61 | CD14分子(CD14)活性蛋白 | Cell?culture;?Activity?Assays. |
| EPA685Hu61 | CD14分子(CD14)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| EPA685Hu64 | CD14分子(CD14)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA685Hu01 | CD14分子(CD14)多克隆抗體 | WB; IHC; ICC; IP. |
| PAA685Hu06 | CD14分子(CD14)多克隆抗體 | WB; IHC; ICC; IP. |
| PAA685Hu02 | CD14分子(CD14)多克隆抗體 | WB; IHC; ICC; IP. |
| FAA685Hu01 | 抗CD14分子(CD14)多克隆抗體 | Flow cytometry. |
| FAA685Hu03 | 抗CD14分子(CD14)多克隆抗體 | Flow cytometry. |
| LAA685Hu71 | CD14分子(CD14)多克隆抗體(生物素標記) | WB; IHC; ICC. |
| MAA685Hu27 | CD14分子(CD14)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA685Hu29 | CD14分子(CD14)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA685Hu23 | CD14分子(CD14)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA685Hu22 | CD14分子(CD14)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA685Hu21 | CD14分子(CD14)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA685Hu24 | CD14分子(CD14)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA685Hu25 | CD14分子(CD14)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA685Hu26 | CD14分子(CD14)單克隆抗體 | WB; IHC; ICC; IP. |
| RAA685Hu25 | CD14分子(CD14)重組抗體 | WB; IF; ICC; IHC; IP; FCM. |
| FAA685Hu02 | 抗CD14分子(CD14)單克隆抗體 | FCM |
| FAA685Hu08 | 抗CD14分子(CD14)單克隆抗體 | Flow cytometry. |
| FAA685Hu06 | 抗CD14分子(CD14)單克隆抗體 | Flow cytometry. |
| FAA685Hu04 | 抗CD14分子(CD14)單克隆抗體 | Flow cytometry. |
| FAA685Hu86 | 抗CD14分子(CD14)單克隆抗體(異硫氰酸熒光素標記) | FCM |
| SEA685Hu | CD14分子(CD14)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA685Hu | CD14分子(CD14)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| KSA685Hu01 | CD14分子(CD14)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻
| 雜志 | 參考文獻 |
| Journal of Pharmacology and Experimental Therapeutics | Successful Treatment of Acute Lung Injury with Pitavastatin in Septic Mice: Potential Role of Glucocorticoid Receptor Expression in Alveolar Macrophages [Aspet: 171462] |
| Tumour Biol | Elevated serum soluble CD15 levels in chronic HBV infection are significantly associated with HBV-related hepatocellular carcinoma [PubMed: 26643894] |
| Free Patents online | RHEUMATOID ARTHRITIS RELATED BIOMARKER [20170350884] |
| Intensive Care Research | Evaluating the Roles of sCD14 and sCD14-ST in Diagnosing COPD and Predicting an Acute Exacerbation of COPD [] |
留言咨詢
